NCT04158401

Brief Summary

The goal of this cross sectional study is to evaluate the differences in cervical stiffness between patients who present for cerclage placement versus normal pregnancies. The central hypothesis is that women for whom a cerclage is indicated will have cervical stiffness measurements lower than normal controls. Cervical stiffness will be objectively measured by the closing pressure Pcl using the Pregnolia measurement device. This is performed during a speculum exam by placing the measurement probe on the ectocervix. In current clinical care, there is no objective measurement of cervical stiffness. An accurate measurement of cervical stiffness that correlates with clinical outcome will advance the field. Successful completion of the current study will spark future studies that correlate cervical stiffness pcl in a prospective study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 8, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

January 15, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

2.4 years

First QC Date

October 23, 2019

Last Update Submit

September 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cervical stiffness (Pcl)

    The primary outcome will be cervical stiffness, Pcl in patients presenting for cerclage versus normal controls.

    5 minutes

Secondary Outcomes (2)

  • Delivery data

    up to 10 months

  • Newborn outcomes

    up to 10 months

Study Arms (4)

Control group

Pregnant patients between 12w0d and 22w0d who present for prenatal care.

Device: Pregnolia

Cerclage group A

Patients who present for a history-indicated cerclage placement.

Device: Pregnolia

Cerclage group B

Patients who present for an ultrasound-indicated cerclage placement.

Device: Pregnolia

Cerclage group C

Patients who present for an exam-indicated cerclage placement.

Device: Pregnolia

Interventions

PregnoliaDEVICE

The Pregnolia measurement device (CE Mark for commercialization in the EU) will be used to measure the cervical stiffness (Pcl) on all subjects.

Cerclage group ACerclage group BCerclage group CControl group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients need to be pregnant.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We are studying pregnant patients between 12w0d and 22w6d.

You may qualify if:

  • Pregnant women over 18 years of age.
  • Singleton gestation.
  • Gestational ages between 12w0d and 22w6d.
  • Candidates for cerclage
  • Normal controls, which will be matched to cerclage subjects by gestational age and parity

You may not qualify if:

  • Multiple gestation pregnancy.
  • Pregnancy complications: Premature rupture of membranes, Placental abruption, Placenta previa/accreta.
  • Chorioamnionitis
  • Preterm contractions
  • History of cervical surgery (LEEP, trachelectomy, conization).
  • Mullarian anomaly
  • Known carrier or HIV or Hepatitis B/C
  • Active genital infection
  • Communication problems (cognitively impaired adults unable to give consent)
  • Cerclage placement already performed this pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts Medical Center

Boston, Massachusetts, 02122, United States

Location

Related Publications (14)

  • Lorenz JM. The outcome of extreme prematurity. Semin Perinatol. 2001 Oct;25(5):348-59. doi: 10.1053/sper.2001.27164.

    PMID: 11707021BACKGROUND
  • Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 Jan 5;371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4.

    PMID: 18177778BACKGROUND
  • Gilbert WM, Nesbitt TS, Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol. 2003 Sep;102(3):488-92. doi: 10.1016/s0029-7844(03)00617-3.

    PMID: 12962929BACKGROUND
  • Iams JD, Johnson FF, Sonek J, Sachs L, Gebauer C, Samuels P. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol. 1995 Apr;172(4 Pt 1):1097-103; discussion 1104-6. doi: 10.1016/0002-9378(95)91469-2.

    PMID: 7726247BACKGROUND
  • Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, Rubens C, Menon R, Van Look PF. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010 Jan;88(1):31-8. doi: 10.2471/BLT.08.062554. Epub 2009 Sep 25.

    PMID: 20428351BACKGROUND
  • Mazza E, Parra-Saavedra M, Bajka M, Gratacos E, Nicolaides K, Deprest J. In vivo assessment of the biomechanical properties of the uterine cervix in pregnancy. Prenat Diagn. 2014 Jan;34(1):33-41. doi: 10.1002/pd.4260.

    PMID: 24155152BACKGROUND
  • Hollenstein M, Bugnard G, Joos R, Kropf S, Villiger P, Mazza E. Towards laparoscopic tissue aspiration. Med Image Anal. 2013 Dec;17(8):1037-45. doi: 10.1016/j.media.2013.06.001. Epub 2013 Jun 19.

    PMID: 23876854BACKGROUND
  • Badir S, Bajka M, Mazza E. A novel procedure for the mechanical characterization of the uterine cervix during pregnancy. J Mech Behav Biomed Mater. 2013 Nov;27:143-53. doi: 10.1016/j.jmbbm.2012.11.020. Epub 2012 Dec 11.

    PMID: 23274486BACKGROUND
  • Badir S, Mazza E, Zimmermann R, Bajka M. Cervical softening occurs early in pregnancy: characterization of cervical stiffness in 100 healthy women using the aspiration technique. Prenat Diagn. 2013 Aug;33(8):737-41. doi: 10.1002/pd.4116. Epub 2013 Apr 29.

    PMID: 23553612BACKGROUND
  • Bauer M, Mazza E, Jabareen M, Sultan L, Bajka M, Lang U, Zimmermann R, Holzapfel GA. Assessment of the in vivo biomechanical properties of the human uterine cervix in pregnancy using the aspiration test: a feasibility study. Eur J Obstet Gynecol Reprod Biol. 2009 May;144 Suppl 1:S77-81. doi: 10.1016/j.ejogrb.2009.02.025. Epub 2009 Mar 13.

    PMID: 19285777BACKGROUND
  • Bauer M, Mazza E, Nava A, Zeck W, Eder M, Bajka M, Cacho F, Lang U, Holzapfel GA. In vivo characterization of the mechanics of human uterine cervices. Ann N Y Acad Sci. 2007 Apr;1101:186-202. doi: 10.1196/annals.1389.004. Epub 2007 Mar 15.

    PMID: 17363446BACKGROUND
  • Mazza E, Nava A, Bauer M, Winter R, Bajka M, Holzapfel GA. Mechanical properties of the human uterine cervix: an in vivo study. Med Image Anal. 2006 Apr;10(2):125-36. doi: 10.1016/j.media.2005.06.001. Epub 2005 Sep 6.

    PMID: 16143559BACKGROUND
  • Mazza E, Nava A, Hahnloser D, Jochum W, Bajka M. The mechanical response of human liver and its relation to histology: an in vivo study. Med Image Anal. 2007 Dec;11(6):663-72. doi: 10.1016/j.media.2007.06.010. Epub 2007 Jul 5.

    PMID: 17719834BACKGROUND
  • ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014 Feb;123(2 Pt 1):372-379. doi: 10.1097/01.AOG.0000443276.68274.cc.

    PMID: 24451674BACKGROUND

MeSH Terms

Conditions

Uterine Cervical IncompetencePremature Birth

Condition Hierarchy (Ancestors)

Uterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesAbortion, HabitualAbortion, SpontaneousPregnancy ComplicationsGenital DiseasesObstetric Labor, PrematureObstetric Labor Complications

Study Officials

  • Michael House, MD

    Tufts Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2019

First Posted

November 8, 2019

Study Start

January 15, 2020

Primary Completion

June 15, 2022

Study Completion

June 15, 2022

Last Updated

September 21, 2022

Record last verified: 2022-09

Locations